Key Insights

Highlights

Success Rate

100% trial completion (above average)

Published Results

14 trials with published results (24%)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

0.0%

0 terminated out of 58 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

14%

8 trials in Phase 3/4

Results Transparency

42%

14 of 33 completed with results

Key Signals

14 with results100% success

Data Visualizations

Phase Distribution

52Total
Not Applicable (20)
Early P 1 (1)
P 1 (4)
P 2 (19)
P 3 (4)
P 4 (4)

Trial Status

Completed33
Unknown11
Recruiting8
Not Yet Recruiting3
Withdrawn2
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 33 completed trials

Clinical Trials (58)

Showing 20 of 20 trials
NCT07534865Not ApplicableRecruitingPrimary

Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts

NCT00867269Recruiting

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

NCT00967785Phase 1Recruiting

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

NCT07457918Phase 3Not Yet Recruiting

Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

NCT07396714Early Phase 1Not Yet RecruitingPrimary

the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.

NCT07246590Phase 3Recruiting

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)

NCT07329907Phase 2CompletedPrimary

Combination Therapy for Warts: Candida Antigen vs. Topical Keratolytic

NCT05087849Phase 1Completed

Intralesional HPV Vaccine for Condylomata

NCT06827938Not ApplicableRecruitingPrimary

Multicenter Real-World Study of Hyperthermia in Warts of Special Population

NCT05291845Phase 2RecruitingPrimary

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts

NCT06973473Not Yet RecruitingPrimary

Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts:Randomized Comparative Trial.

NCT05799157Phase 2Completed

Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts

NCT00472459Phase 3Completed

Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer

NCT06214559Not ApplicableCompletedPrimary

Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts.

NCT06833164CompletedPrimary

ERAP1,2 in Recalcitrant Warts

NCT06812065Not ApplicableRecruitingPrimary

Randomized Controlled Clinical Trial of Hyperthermia and Hydrogen Peroxide 3% in the Treatment of Cutaneous Warts

NCT03981822Phase 2Completed

A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts

NCT03487549Phase 2Completed

Cantharidin and Occlusion in Verruca Epithelium

NCT05781841CompletedPrimary

Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts

NCT05371834Not ApplicableActive Not RecruitingPrimary

Microwave Treatment of Common and Plantar Warts

Scroll to load more

Research Network

Activity Timeline